Patents by Inventor Marc N. Agnew

Marc N. Agnew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5264575
    Abstract: Novel 2,6-methano-1,3-benzodiazocines, intermediates, processes for the preparation thereof, and methods for alleviating pain and for alleviating various memory dysfunctions characterized by a decreased cholinergic function, such as Alzheimer's disease, utilizing compounds or compositions thereof are disclosed.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: November 23, 1993
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventors: Richard C. Allen, Marc N. Agnew, David M. Fink
  • Patent number: 5097033
    Abstract: Novel 2,6-methano-1,3-benzodiazocines, intermediates, processes for the preparation thereof, and methods for alleviating pain and for alleviating various memory dysfunctions characterized by a decreased cholinergic function, such as Alzheimer's disease, utilizing compounds or compositions thereof are disclosed.
    Type: Grant
    Filed: January 9, 1991
    Date of Patent: March 17, 1992
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventors: Richard C. Allen, Marc N. Agnew, David M. Fink
  • Patent number: 5010083
    Abstract: Novel 2,6-methano-1,3-benzodiazocines, intermediates, processes for the preparation thereof, and methods for alleviating pain and for alleviating various memory dysfunctions characterized by a decreased cholinergic function, such as Alzheimer's disease, utilizing compounds or compositions thereof are disclosed.
    Type: Grant
    Filed: December 6, 1989
    Date of Patent: April 23, 1991
    Assignee: Hoechst-Roussel Pharmaceuticals, Inc.
    Inventors: Richard C. Allen, Marc N. Agnew, David M. Fink